Breast Cancer Research and Treatment

Title Publication Date Language Citations
The role of intratumoral and systemic IL-6 in breast cancer2013/03/27English258
bc-GenExMiner: an easy-to-use online platform for gene prognostic analyses in breast cancer2011/03/31English257
Depression, quality of life and breast cancer: a review of the literature2007/08/03English254
Adherence to tamoxifen over the five-year course2006/03/16English253
MCF-7 breast carcinoma cells do not express caspase-32008/10/14English248
The natural history of ductal carcinoma in situ of the breast: a review2005/12/01English247
Palbociclib plus letrozole as first-line therapy in estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer with extended follow-up2019/01/10English245
The presence of programmed death 1 (PD-1)-positive tumor-infiltrating lymphocytes is associated with poor prognosis in human breast cancer2013/06/01English243
HER2 signaling pathway activation and response of breast cancer cells to HER2-targeting agents is dependent strongly on the 3D microenvironment2009/08/22English241
Exosomal miR-221/222 enhances tamoxifen resistance in recipient ER-positive breast cancer cells2014/07/10English239
Cognitive function in breast cancer patients prior to adjuvant treatment2007/08/03English238
Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. the COVID-19 pandemic breast cancer consortium2020/04/24English235
HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial2010/09/22English235
Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer – results of the ALMANAC validation phase2006/03/16English234
Social determinants of breast cancer risk, stage, and survival2019/07/03English232
Response to neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients2008/07/23English231
Triple negative breast cancer: unmet medical needs2010/12/15English229
Obesity as a risk factor for triple-negative breast cancers: a systematic review and meta-analysis2012/11/20English229
Reproductive risk factors and breast cancer subtypes: a review of the literature2014/01/30English229
Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)2011/12/25English228
Soy isoflavones consumption and risk of breast cancer incidence or recurrence: a meta-analysis of prospective studies2010/11/27English223
Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients2007/10/06English222
Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study2010/08/06English219
Association of genetic variation in tamoxifen-metabolizing enzymes with overall survival and recurrence of disease in breast cancer patients2005/06/01English217
Psychological distress and fatigue predicted recurrence and survival in primary breast cancer patients2007/01/03English216
Tumor-infiltrating lymphocytes are correlated with response to neoadjuvant chemotherapy in triple-negative breast cancer2011/05/12English213
Evidence for biological effects of metformin in operable breast cancer: a pre-operative, window-of-opportunity, randomized trial2011/06/08English213
Tumor–stroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple-negative carcinoma patients2010/04/02English213
Disparities in breast cancer characteristics and outcomes by race/ethnicity2010/10/07English211
Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer2007/12/04English211